IL150290A0 - The use of mirtazapine for the treatment of sleep disorders - Google Patents

The use of mirtazapine for the treatment of sleep disorders

Info

Publication number
IL150290A0
IL150290A0 IL15029001A IL15029001A IL150290A0 IL 150290 A0 IL150290 A0 IL 150290A0 IL 15029001 A IL15029001 A IL 15029001A IL 15029001 A IL15029001 A IL 15029001A IL 150290 A0 IL150290 A0 IL 150290A0
Authority
IL
Israel
Prior art keywords
mirtazapine
treatment
sleep disorders
sleep
disorders
Prior art date
Application number
IL15029001A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL150290A0 publication Critical patent/IL150290A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15029001A 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders IL150290A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11
PCT/EP2001/001221 WO2001058453A1 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Publications (1)

Publication Number Publication Date
IL150290A0 true IL150290A0 (en) 2002-12-01

Family

ID=8171013

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15029001A IL150290A0 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders
IL150290A IL150290A (en) 2000-02-11 2002-06-18 Use of mirtazapine for preparation of a medicament for the treatment of sleep disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150290A IL150290A (en) 2000-02-11 2002-06-18 Use of mirtazapine for preparation of a medicament for the treatment of sleep disorders

Country Status (25)

Country Link
US (1) US6933293B2 (xx)
EP (4) EP1656937A1 (xx)
JP (1) JP5039994B2 (xx)
KR (1) KR20020069371A (xx)
CN (2) CN101229170A (xx)
AR (1) AR027394A1 (xx)
AT (1) ATE317261T1 (xx)
AU (1) AU780439B2 (xx)
BR (1) BR0108261A (xx)
CA (1) CA2396209C (xx)
CO (1) CO5271706A1 (xx)
CZ (1) CZ302368B6 (xx)
DE (1) DE60117122T2 (xx)
DK (1) DK1257278T3 (xx)
ES (1) ES2258071T3 (xx)
HK (1) HK1049122B (xx)
HU (1) HUP0204391A3 (xx)
IL (2) IL150290A0 (xx)
NO (1) NO328007B1 (xx)
PE (1) PE20011080A1 (xx)
PL (1) PL206073B1 (xx)
RU (1) RU2270680C2 (xx)
SK (1) SK287396B6 (xx)
WO (1) WO2001058453A1 (xx)
ZA (1) ZA200205238B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
EP1806133A1 (en) * 2004-10-14 2007-07-11 Daikin Industries, Ltd. Method for modifying the ambience, and spray liquid and sprayer used in the method
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
CN101679431B (zh) 2007-04-11 2013-08-14 Msd欧斯股份有限公司 制备四环苯并氮杂卓的对映异构体的方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
WO1999025356A1 (en) * 1997-11-14 1999-05-27 Akzo Nobel N.V. Use of mirtazapine for treating sleep apneas

Also Published As

Publication number Publication date
CZ20022330A3 (cs) 2002-11-13
KR20020069371A (ko) 2002-08-30
NO20023803D0 (no) 2002-08-09
HK1049122A1 (en) 2003-05-02
RU2270680C2 (ru) 2006-02-27
CZ302368B6 (cs) 2011-04-13
NO328007B1 (no) 2009-11-09
WO2001058453A1 (en) 2001-08-16
JP2003522147A (ja) 2003-07-22
CN101229170A (zh) 2008-07-30
PL206073B1 (pl) 2010-06-30
AR027394A1 (es) 2003-03-26
AU780439B2 (en) 2005-03-24
EP1658850A1 (en) 2006-05-24
CN1395487A (zh) 2003-02-05
PL356721A1 (en) 2004-06-28
JP5039994B2 (ja) 2012-10-03
DE60117122D1 (de) 2006-04-20
EP1257278A1 (en) 2002-11-20
IL150290A (en) 2010-12-30
PE20011080A1 (es) 2001-10-18
ZA200205238B (en) 2003-09-29
EP2283840A1 (en) 2011-02-16
BR0108261A (pt) 2003-03-05
RU2002124141A (ru) 2004-03-10
EP1656937A1 (en) 2006-05-17
AU3024701A (en) 2001-08-20
ES2258071T3 (es) 2006-08-16
CO5271706A1 (es) 2003-04-30
HK1049122B (zh) 2006-04-21
EP1257278B1 (en) 2006-02-08
NO20023803L (no) 2002-10-09
SK11442002A3 (sk) 2003-02-04
ATE317261T1 (de) 2006-02-15
DK1257278T3 (da) 2006-06-12
US6933293B2 (en) 2005-08-23
HUP0204391A3 (en) 2005-03-29
SK287396B6 (sk) 2010-08-09
HUP0204391A2 (en) 2003-05-28
DE60117122T2 (de) 2006-07-27
CA2396209C (en) 2009-09-01
US20030022888A1 (en) 2003-01-30
CA2396209A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
HK1152243A1 (en) Vegf for use in the treatment of central nervous system disorders vegf
IL160389A0 (en) Use of flibanserin for the treatment of sexual disorders
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
HK1053058A1 (zh) 普拉克索用於治療成癮性疾病的用途
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
IL157145A0 (en) Use of dc23 antagonists for the treatment of neoplastic disorders
IL155433A0 (en) Treatment of t cell disorders
GB0004531D0 (en) The treatment of respiratory diseases
IL150289A0 (en) Drug combination for the treatment of depression and related disorders comprising mirtazapine
HK1049122A1 (en) The use of mirtazapine for the treatment of sleep disorders
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB0128674D0 (en) Treatment of sleep disorders and the like
IL155874A0 (en) Treatment of anxiety disorders
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
PL351554A1 (en) Osanetant in the treatment of mood disorders
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
AU4838301A (en) Treatment of disorders relating to the serotonergic system
EP1357834A4 (en) DIAGNOSTIC OF BREATHING BREATHING DISORDERS
GB0010496D0 (en) Treatment of conditions of the central nervous system
IL153788A0 (en) Treatment of eating disorders using carboxyalkylethers
GB0003228D0 (en) Treatment of GI disorders